- Home
- VELO vs CVM Comparison
VELO vs CVM Comparison
Compare VELO & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VELO
- CVM
- Stock Information
- Founded
- VELO 2014
- CVM 1983
- Country
- VELO United States
- CVM United States
- Employees
- VELO N/A
- CVM N/A
- Industry
- VELO Industrial Machinery/Components
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VELO Technology
- CVM Health Care
- Exchange
- VELO Nasdaq
- CVM Nasdaq
- Market Cap
- VELO 85.8M
- CVM 71.8M
- IPO Year
- VELO N/A
- CVM 1987
- Fundamental
- Price
- VELO $3.60
- CVM $10.47
- Analyst Decision
- VELO
- CVM
- Analyst Count
- VELO 0
- CVM 0
- Target Price
- VELO N/A
- CVM N/A
- AVG Volume (30 Days)
- VELO 1.4M
- CVM 328.8K
- Earning Date
- VELO 11-07-2025
- CVM 08-14-2025
- Dividend Yield
- VELO N/A
- CVM N/A
- EPS Growth
- VELO N/A
- CVM N/A
- EPS
- VELO N/A
- CVM N/A
- Revenue
- VELO $43,765,000.00
- CVM N/A
- Revenue This Year
- VELO N/A
- CVM N/A
- Revenue Next Year
- VELO N/A
- CVM N/A
- P/E Ratio
- VELO N/A
- CVM N/A
- Revenue Growth
- VELO N/A
- CVM N/A
- 52 Week Low
- VELO $1.43
- CVM $1.98
- 52 Week High
- VELO $29.25
- CVM $39.30
- Technical
- Relative Strength Index (RSI)
- VELO N/A
- CVM 55.16
- Support Level
- VELO N/A
- CVM $8.65
- Resistance Level
- VELO N/A
- CVM $12.68
- Average True Range (ATR)
- VELO 0.00
- CVM 1.28
- MACD
- VELO 0.00
- CVM -0.03
- Stochastic Oscillator
- VELO 0.00
- CVM 44.67
About VELO Velo3D Inc. Common stock
Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.